Amy Yang

Amy Yang
Amy joined the Thomas Jefferson College of Population Health team after receiving her PharmD from Northeastern University in Boston, MA in 2021. In her role as a post-doctoral fellow, Amy is able to assist in and lead outcomes research projects, while earning her Masters in Applied Health Economics and Outcomes Research. Her first year will be spent at JCPH, before moving to Teva, her sponsor company, during her second year. While at Jefferson, she has been contributing to research projects with Dartmouth and Jefferson’s Multiple Sclerosis Continuous Quality Improvement (MSCQI) teams, and other internal and external groups. Her work has led to multiple abstract submissions and contributions to manuscripts. Her current research interests involve concomitant drug usage, neurology, and oncology.
Speaking seminar: Center-Level and Socioeconomic Variation in Patient Health Questionnaire-9 (PHQ-9) Depression Scores: Real-World Evidence from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative Study (2017-2020).